Lv1
18 积分 2024-03-17 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
4个月前
已完结
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
5个月前
已完结
Gene editing therapeutics based on mRNA delivery
5个月前
已完结
Success in Sight for Gene Editing
5个月前
已完结
Genetic Perturbation of Pyruvate Dehydrogenase Kinase 1 Modulates Growth, Angiogenesis and Metabolic Pathways in Ovarian Cancer Xenografts
9个月前
已完结
Anti-EpCAM-conjugated adeno-associated virus serotype 2 for systemic delivery of EGFR shRNA: Its retargeting and antitumor effects on OVCAR3 ovarian cancer in vivo
9个月前
已完结
Forks in the road for CAR T and CAR NK cell cancer therapies
10个月前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
10个月前
已完结
皖公网安备34019202002308
